Latest Period
Q2 2026
Security Snapshot
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) Institutional Ownership
CUSIP: 21900C308
13F Institutional Holders and Ownership History from Q1 2019 to Q2 2026
Institutions Reporting
191
Shares (Excl. Options)
43,908,439
Price
$7.85
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
- Symbol
- CRMD on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 43,908,439
- Total 13F value
- $344,547,254
- Portfolio coverage rank
- 0%
- Share change
- +2,844,093
- Value change
- +$23,233,182
- Number of holders
- 191
- Shares outstanding
- 78,279,847
- SEC-reported price per share
- $7.49
- Insider filing price
- $7.49
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE is tracked under CUSIP 21900C308.
- 191 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 185 to 191 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $278,890,507 to $344,547,254.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 191 institutions filings for Q2 2026.
Security key
21900C308
Latest holder period
Q2 2026
13F holders
191
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
CRMD full holder history
CorMedix Inc. SEC filings
CorMedix Inc. company facts
CorMedix Inc. insider transactions
CorMedix Inc. 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 21900C308:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
CRMD
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 7.9% | +28% | $44,985,125 | +$9,454,283 | 6,274,076 | +27% | Deep Track Capital, LP | 31 Mar 2026 |
| SHAIBATALHAMD AYMEN ABDALKADER | 5.9% | +1.7% | $34,685,018 | +$139,018 | 4,618,511 | +0.4% | SHAIBATALHAMD AYMEN ABDALKADER | 11 Jun 2026 |
| BlackRock, Inc. | 7.5% | $41,659,221 | 4,567,897 | BlackRock, Inc. | 31 Dec 2024 |
As of 30 Jun 2026, 191 institutional investors reported holding 43,908,439 shares of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD). This represents 56% of the company’s total 78,279,847 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
45%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.1% | 6,324,111 | +6% | 0% | $49,644,269 |
| Deep Track Capital, LP | 8% | 6,274,076 | 0% | 0.73% | $49,251,497 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 3,135,075 | +0.17% | 0% | $24,610,339 |
| STATE STREET CORP | 3% | 2,316,845 | +5.7% | 0% | $18,187,233 |
| ROYCE & ASSOCIATES LP | 2.8% | 2,176,362 | +15% | 0.14% | $17,084,442 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 1,947,014 | +7.2% | 0% | $15,286,964 |
| UBS Group AG | 2.4% | 1,877,940 | +22% | 0% | $14,741,829 |
| OBERWEIS ASSET MANAGEMENT INC/ | 1.7% | 1,323,915 | +9.3% | 0.21% | $10,392,733 |
| Alyeska Investment Group, L.P. | 1.1% | 850,000 | 0% | 0.02% | $6,672,500 |
| MARSHALL WACE, LLP | 1% | 779,535 | +55% | 0.01% | $6,119,350 |
| NORTHERN TRUST CORP | 0.97% | 756,430 | +19% | 0% | $5,937,976 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.91% | 708,604 | -4.6% | 0% | $5,562,541 |
| Pacer Advisors, Inc. | 0.81% | 633,978 | +9.2% | 0.01% | $4,977,000 |
| HRT FINANCIAL LP | 0.8% | 625,558 | +114% | 0.01% | $4,910,000 |
| Trexquant Investment LP | 0.8% | 623,797 | +11% | 0.03% | $4,896,806 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.79% | 618,172 | +2.5% | 0% | $4,852,650 |
| ARMISTICE CAPITAL, LLC | 0.64% | 500,000 | 0.11% | $3,925,000 | |
| VANGUARD FIDUCIARY TRUST CO | 0.62% | 484,322 | -4.2% | 0% | $3,801,928 |
| GOLDMAN SACHS GROUP INC | 0.6% | 466,393 | -8.8% | 0% | $3,661,185 |
| RAYMOND JAMES FINANCIAL INC | 0.57% | 446,142 | +36% | 0% | $3,502,216 |
| Hennion & Walsh Asset Management, Inc. | 0.56% | 438,629 | +151% | 0.1% | $3,443,238 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.55% | 434,132 | 0.06% | $3,407,936 | |
| Palisades Investment Partners, LLC | 0.54% | 426,543 | -30% | 0.95% | $3,348,363 |
| MORGAN STANLEY | 0.54% | 423,341 | -2.8% | 0% | $3,323,231 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.54% | 419,284 | -38% | 0.06% | $3,291,379 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
30
Latest
Q2 2026
Rows shown
1-25 of 30
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 43,908,439 | $344,547,254 | +$23,233,182 | $7.85 | 191 |
| 2026 Q1 | 41,076,245 | $278,890,507 | -$24,958,090 | $6.79 | 185 |
| 2025 Q4 | 41,963,960 | $487,974,048 | -$15,316,010 | $11.63 | 200 |
| 2025 Q3 | 43,121,910 | $501,528,237 | +$101,799,375 | $11.63 | 189 |
| 2025 Q2 | 34,151,234 | $420,699,898 | +$142,837,808 | $12.32 | 169 |
| 2025 Q1 | 23,724,937 | $146,235,596 | +$397,499 | $6.16 | 135 |
| 2024 Q4 | 22,893,836 | $185,441,545 | +$29,955,443 | $8.10 | 126 |
| 2024 Q3 | 19,135,638 | $154,655,147 | +$21,831,393 | $8.08 | 100 |
| 2024 Q2 | 17,129,390 | $74,162,669 | -$748,246 | $4.33 | 97 |
| 2024 Q1 | 17,269,642 | $73,216,929 | -$5,693,027 | $4.24 | 89 |
| 2023 Q4 | 18,742,007 | $70,461,032 | +$3,045,526 | $3.76 | 101 |
| 2023 Q3 | 17,891,223 | $66,197,207 | -$5,485,628 | $3.70 | 92 |
| 2023 Q2 | 19,187,043 | $76,065,204 | +$33,053,416 | $3.96 | 86 |
| 2023 Q1 | 10,770,110 | $44,582,136 | -$1,863,278 | $4.14 | 64 |
| 2022 Q4 | 11,182,776 | $47,050,210 | +$1,816,100 | $4.22 | 62 |
| 2022 Q3 | 10,928,271 | $31,131,890 | -$4,497,215 | $2.83 | 66 |
| 2022 Q2 | 12,425,504 | $49,348,797 | -$5,601,808 | $4.02 | 69 |
| 2022 Q1 | 13,362,668 | $73,354,516 | +$1,886,576 | $5.48 | 83 |
| 2021 Q4 | 13,046,114 | $59,435,463 | +$5,549,733 | $4.55 | 78 |
| 2021 Q3 | 11,793,247 | $54,910,109 | +$1,590,384 | $4.65 | 75 |
| 2021 Q2 | 11,351,356 | $77,873,368 | +$3,221,689 | $6.86 | 77 |
| 2021 Q1 | 10,781,064 | $107,630,096 | +$16,345,897 | $9.99 | 76 |
| 2020 Q4 | 9,261,298 | $68,791,909 | +$7,239,796 | $7.43 | 74 |
| 2020 Q3 | 8,327,514 | $50,205,664 | +$9,581,252 | $6.03 | 70 |
| 2020 Q2 | 6,739,459 | $42,456,689 | +$1,328,313 | $6.30 | 67 |